American Shared Hospital Services (NYSE American: AMS), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will release its fourth quarter and full year 2025 financial results before the market opens on March 31, 2026. The company will hold a conference call at 12:00 p.m. ET on the same day to discuss the results.
The conference call will be accessible to domestic callers by dialing 1-844-413-3972 and to international callers by dialing 1-412-317-5776 at least 10 minutes prior to the start time. Participants should ask to join the American Shared Hospital Services call. A simultaneous webcast will be available through the company's website at www.ashs.com or directly at this link. A replay of the call will be available from 1-855-669-9658 or 1-412-317-0088, access code 6331493, through April 7, 2026, and will also be archived on the company's website.
This announcement comes as American Shared Hospital Services continues to expand its turnkey solutions for cancer treatment centers in North and South America. The company provides integrated cancer care, including Gamma Knife, proton therapy, and advanced radiation therapy services, often through health system partnerships where both parties share capital investment and profitability. The financial results will offer investors and analysts a detailed look at the company's performance over the past year and its growth trajectory in the cancer treatment market.
Investors should note that the company's forward-looking statements involve risks and uncertainties, including economic and market conditions, variability of financial results between quarters, changes to CMS reimbursement rates, and the timing and financing of business expansions. Further details on these factors are available in the company's SEC filings, including its quarterly and annual reports.
For more information about American Shared Hospital Services and its services, visit www.ashs.com.
